If you noticed CRISPR stocks taking a ~20% hit this morning, a study (notably not yet peer reviewed) was released that suggests a substantial percentage of people may have immune responses to Cas9.
Engadget Article for a quick summary.
For those that follow CRISPR companies particularly closely, what are your thoughts on potential impact going forward? In the event that the study is accurate, I'd be curious about the feasibility of alternatives, timelines in which they might be implemented, etc.
Submitted January 08, 2018 at 10:38AM by devEdevs http://ift.tt/2mbOPWW
